Effect of Mass Drug Administration with a Single Dose of Albendazole on Ascaris lumbricoides and Trichuris trichiura Infection among Schoolchildren in Yangon Region, Myanmar
Article information
Abstract
Soil-transmitted helminths, including Ascaris lumbricoides and Trichuris trichiura, are important intestinal parasites mostly affecting younger people in developing countries. In 2014–2015, we performed mass fecal examinations targeting a total of 2,227 schoolchildren in 3 districts (South Dagon, North Dagon, and Hlaing-thar-yar) of Yangon Region, Myanmar, using the Kato-Katz thick smear technique. The egg positive children were subjected to a mass drug administration (MDA) using a single oral dose of 400 mg albendazole. The pre-treatment egg positive rate (EPG/person) of A. lumbricoides averaged 17.2% (15,532); it was 25.2% (21,796), 14.2% (11,816), and 12.8% (12,983) in 3 districts, respectively, and that of T. trichiura averaged 19.4% (1,074), and was 24.1% (1,040), 12.3% (852), and 21.2% (1,330) in 3 districts, respectively. Follow-up fecal examinations performed 4 months post-MDA revealed considerable decreases of A. lumbricoides prevalence (EPG/person) to av. 8.3% (12,429), and 13.7% (17,640), 8.0% (7,797), and 4.5% (11,849) in 3 districts, respectively. However, T. trichiura did not show any recognizable decrease in the prevalence (EPG/person) remaining at av. 18.2% (862), and 18.5% (888), 11.5% (812), and 23.3% (887) in 3 districts, respectively. The results demonstrated difficulty in short-term control of T. trichiura by MDA using albendazole and suggested necessity of either a long-term MDA (>10 years) or changing the albendazole regimen into 2~3-day course (total 800 or 1,200 mg), or using an alternative drug/drug combination.
Soil-transmitted helminths (STHs), including Ascaris lumbricoides, hookworms, and Trichuris trichiura, are the most common intestinal parasites affecting more than 1.5 billion people worldwide [1]. These infections affect especially children in developing countries and are associated with poor growth, reduced physical activity, and impaired learning ability [2]. In Myanmar, the prevalence of A. lumbricoides and T. trichiura among schoolchildren has been high, whereas that of hookworms has been comparatively low [2–4].
Repeated mass fecal examinations followed by mass drug administration (MDA), environmental sanitation including remodeling of latrines and prohibition of night soil fertilizers, and health education for improving personal hygiene are the 3 basic control strategies for STH infections [5]. Among these, MDA using a proper anthelmintic drug is the most feasible and efficient method. Anthelmintics most popularly used for STH control are albendazole and mebendazole [1]; the recommended regimen of albendazole is 400 mg given in a single dose [4,6], and that of mebendazole is 100 mg in a single dose [6]. However, the sensitivity of each helminth species to MDA and anthelmintic drugs varies depending on the species (A. lumbricoides, hookworms, or T. trichiura) and might also be associated with drug resistance of helminths [1].
The Korea Association of Health Promotion (KAHP), Seoul, Korea undertook an international health promotion project entitled, “Korea-Myanmar Health Promotion Project for Elementary Schoolchildren of the Vulnerable Areas around Yangon, Myanmar”. The main purpose of the project was intestinal parasite control among schoolchildren under the agreement between 2 countries (as of 16 June 2013; IRB was not available at the time of this survey). In 2014–2015, we performed mass fecal examinations targeting schoolchildren in 20 Basic Education Primary Schools (BEPS) located in 3 districts (South Dagon, North Dagon, and Hlaing-thar-yar) of Yangon Region. MDA was performed on egg positive children using a single oral dose of albendazole. Follow-up fecal examinations were done 4 months later. The short-term (4-month) control efficacy in response to MDA appeared to be quite different between A. lumbricoides (high efficacy) and T. trichiura (poor efficacy). The purpose of this paper is to present the results of MDA with analyses of the factors related to the effect of control.
The 20 BEPS consisted of 6 schools in South Dagon, 6 schools in North Dagon, and 8 schools in Hlaing-thar-yar district (Fig. 1). Fecal examinations were performed on a total of 2,227 schoolchildren (aged 6–8 years, including almost the same numbers of boys and girls) using the Kato-Katz thick smear technique (1 smear per child). The results revealed that the egg positive rate of any kinds of helminths averaged 30.9%; the rate being 40.4% (33.3–52.0% by school) in South Dagon, 21.9% (8.1–54.2%) in North Dagon, and 30.2% (23.0–38.7%) in Hlaing-thar-yar (Table 1). The egg positive rate (EPG/person) of A. lumbricoides averaged 17.2% (15,532), and by district 25.2% (21,796), 14.2% (11,816), and 12.8% (12,983), respectively, and that of T. trichiura averaged 19.4% (1,074), and by district 24.1% (1,040), 12.3% (852), and 21.2% (1,330). The egg positive rate of hookworms was 0.2% on average, and by district 0.1%, 0.1%, and 0.4%, and that of Opisthorchis viverrini/minute intestinal flukes (MIF) averaged 0.1%, and by district 0.1%, 0.0%, and 0.1%, in 3 districts, respectively (Table 1). The results were not significantly different (P>0.05) between boys and girls (data not shown).
MDA was performed on a selective treatment manner, and a total of 688 helminth egg positive cases were given each a single oral dose of 400 mg albendazole (Shinpoong Pharm Co., Seoul, Korea). Two trematode egg positive children were given additionally praziquantel 40 mg/kg in a single dose. The MDA coverage rate exceeded 95–98% in each school but there were a few children dropped-out from the MDA (data not shown). The significance of differences in the prevalence before and after the MDA were statistically evaluated using the student’s t-test.
At 4 months after the MDA, follow-up fecal examinations (1 Kato-Katz smear for each child) were performed on the same schools, and the efficacy of the MDA for reduction of A. lumbricoides and T. trichiura prevalence and worm burden was assessed. Possible bias due to a few new attendees in each school was neglected. The efficacy of the MDA was evaluated to be fairly satisfactory for A. lumbricoides as the pre-treatment average egg positive rate of 17.2% was decreased to lower than half level, 8.3% (P<0.05) (Fig. 2), and the pre-treatment EPG/person of 15,532 decreased to 12,429 after the MDA (P>0.05) (Fig. 3). This decreasing trend of A. lumbricoides was similar among 3 districts (Figs. 2, 3) and also recognizable among different schools, although some schools, like BEPS-A, B, I, and Q, showed no significant decreases in the prevalence (P>0.05) (data not shown).
However, the efficacy of the MDA against T. trichiura was far from satisfactory (Fig. 2). The average pre-treatment egg positive rate, 19.4%, in 3 districts was not significantly decreased after the MDA which remained at 18.2% at follow-up examinations (P>0.05) (Fig. 2), although the average EPG of infected schoolchildren was decreased a little, from 1,074 to 862 (P>0.05) (Fig. 3). Insignificant and minor decreasing trends (P>0.05) were seen in 2 districts, South Dagon and North Dagon (Figs. 2, 3), and a slight increase (P>0.05) in the prevalence vs a remarkable decrease in EPG/person appeared in Hlaing-thar-yar district (Figs. 2, 3). The majority of individual schools revealed more or less decreasing trends, while some of them, including BEPS-H, O, Q, R, and T schools, showed slightly increasing trends in the prevalence of T. trichiura (data not shown).
The high sensitivity of A. lumbricoides to benzimidazoles (albendazole and mebendazole) has been well documented [6,7]. The cure rate of albendazole (400 mg) for A. lumbricoides infection was reported to be 82–100% [6] or 93.2–97.3% [7]. However, the sensitivity of T. trichiura to albendazole or mebendazole has been reported to be generally low and unsatisfactory [1,6,7]. The cure rate of 400 mg single oral dose of albendazole for treating T. trichiura infection was reported to be 27–81% [6] or less, 21.0–42.5% [7].
Our study demonstrated that the efficacy of MDA using a single dose of albendazole was fairly good for reduction of the prevalence and intensity of infection of A. lumbricoides (from 17.2% to 8.3% in average egg positive rate and from 15,532 to 12,429 in EPG/person) at 4 months post-MDA. A large portion of 8.3% in prevalence at follow-up was regarded to be due to reinfection during 4 months after the MDA. However, its efficacy was far from satisfactory for short-term control of T. trichiura. The average prevalence before the MDA was 19.4% but it remained to be still high after 4 months, 18.2%. The egg reduction was fairly remarkable in Hlaing-thar-yar district but less remarkable in 2 other districts. The failure in reduction of T. trichiura prevalence could be due to 2 basic factors; one is limitation of the drug efficacy, and the other is rapid reinfection after the MDA. However, the importance of reinfection may not be so great considering the biology and life cycle of T. trichiura. The pre-patent period of T. trichiura was estimated to be 101–114 days in a human volunteer after an experimental intake of eggs [10]. It is thus unlikely that T. trichiura worms reinfected after the MDA produced a sufficient amount of eggs. Therefore, a more important factor may be the drug efficacy limitation of albendazole against T. trichiura.
Various workers have reported limited efficacy of albendazole and mebendazole for individual treatment of T. trichiura infection [1,6–9]. However, these drugs can be used in MDA because of considerable egg reduction rates, 77.0–99.0% [6] or 39.0–60.6% [7]. In particular, a long-term repeated use of albendazole or mebendazole at provincial or national level, up to 10 or more years (once or twice a year), markedly reduced the prevalence of T. trichiura in China [11,12] and also in Cambodia (unpublished observations). In our study, egg reduction of T. trichiura was fairly remarkable after the MDA in Hlaing-thar-yar district. These together indicate that a prolonged use of benzimidazoles must be beneficial for long-term control of T. trichiura.
However, it should be reminded that Moser et al. [1,7] demonstrated a considerable temporal decrease of benzimidazole efficacy against trichuriasis, possibly in part due to an emergence of drug resistance. For example, 73% egg reduction rate of T. trichiura by albendazole in 1995 dropped down to 43% in 2015, and 91% egg reduction rate of T. trichiura by mebendazole in 1995 dropped down to 55% in 2015 [1]. Cure rates of albendazole also fell from 38.6% in 1995 to 16.4% in 2015 [7]. These decreases in efficacy could be explained by study-related confounders or by anthelmintic drug resistance [1]. Further studies are required to identify single nucleotide polymorphisms in the parasite gene which is associated with the drug resistance [1].
Our study clearly demonstrated difficulty in short-term control of T. trichiura by MDA using 400 mg single dose of albendazole and suggested the necessity of either a prolonged use of albendazole or use of an alternative regimen of albendazole or an alternative anthelmintic drug in the surveyed region of Myanmar. In this respect, sustained use of albendazole (400 mg single dose) for more than 10 years, or trial of new regimens of albendazole, for example, 400 mg daily for 2–3 days, might be considered. However, the latter method seems not so feasible and not convenient for MDA, and repeated drug intake in each child may provoke untoward effects. Increasing the single dose of albendazole, for example, to 600 mg revealed no better efficacy than the recommended dose (400 mg) in treating T. trichiura infection [8].
Alternative drugs for T. trichiura include tribendimidine, ivermectin, oxantel pamoate, and moxidectin [1]. One or more of these drugs in combination with albendazole can be new candidates for use against T. trichiura [1,9]. In particular, oxantel pamoate alone or in combination with albendazole showed higher cure and egg reduction rates than albendazole alone [9]. However, oxantel pamoate is currently unavailable in Myanmar and will be expensive if imported from foreign countries. In the study of Speich et al. [9], oxantel pamoate and the matching placebo were self-manufactured at the University of Basel, Switzerland. Albendazole plus ivermectin, albendazole plus tribendimidine, and albendazole plus moxidectin can be other drug combinations for possible use in T. trichiura infection [1].
In our study, the egg positive rate of O. viverrini/MIF among the schoolchildren was very low,<0.1% on average. It is comparable with our previous report from the same districts targeting village people who revealed 0.7% egg prevalence of O. viverrini/MIF among 2,057 subjects examined [13]. The only adult worm (n=1) harvested after chemotherapy and purging of an egg-positive villager was identified as O. viverrini [13]. Some Enterobius vermicularis eggs (among others; Table 1) were also detected from a few schoolchildren; however, this does not reflect the true figure of E. vermicularis infection because anal swab examinations should be done to properly evaluate the status of this nematode infection. It is worth to mention that our group separately performed anal swab examinations on a total of 761 schoolchildren in the same 3 districts of Yangon Region, and the average egg positive rate of E. vermicularis appeared to be very high, 47.2% [14].
Taken together, our study (MDA) using a single oral dose (400 mg) of albendazole showed a successful result for short-term (4 months) control of A. lumbricoides in primary schools of 3 districts in Yangon Region. However, its efficacy was not satisfactory in short-term control of T. trichiura in the same districts. Either prolonged use of albendazole for more than 10 years or changing the albendazole regimen into 2–3-day course (total 800 mg or 1,200 mg), or use of an alternative drug, for example, oxantel pamoate, may bring about better control efficacy against T. trichiura infection in this region.
ACKNOWLEDGMENTS
We are grateful to the teachers and staff of the subjected primary schools in South Dagon, North Dagon, and Hlaing-thar-yar in Yangon Region, Myanmar for their assistance and guidance of the schoolchildren, collection of fecal samples, and MDA using albendazole.
Notes
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest related to this study.